sequentify ltd

General Data

supplementary funding
Reg Number
516309572
Sector
Biomed
Established
2021
No. of Employees
13
Stage
R&D
Additional Funding
1

Description

Sequentify delivers fast, accurate, and affordable genomic sequencing solutions, enabling labs to scale testing in oncology, infectious diseases, and carrier screening.

Technology

Sequentify leverages advanced expertise in molecular and synthetic biology, along with computational genomics, to develop products that empower users to query genomic regions relevant to their specific biological tasks.

Targeted Customers

Genomic laboratories, Infectious Disease, Cancer diagnostics, Carrier screening and COVID-19 surveillance applications.

Management personnel

Tom Fleischer - CEO & Co-Founder

Contact information

Name
Tom Fleischer
Phone
0549285609
Country
Israel
Zip
7638519

Tags

AgriTechBiotechnologyCancerDiagnosticsDigital HealthDNAGenomicsInfectious DiseasesLife SciencesMedTechScreeningSynthetic Biology

Classified Technologies

Biomedicine and pharmaceuticals

Winning details

Route name
Winning year

R&D Program second/third year request for Corporate Startup Corporate
R&D Program second/third year request for Corporate Startup Corporate
2023